GeneDx Holdings Corp (NASDAQ: WGS) started the day on Thursday, with a price decrease of -7.46% at $62.17, before settling in for the price of $67.18 at the close. Taking a more long-term approach, WGS posted a 52-week range of $3.66-$98.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 5.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 94.88%. This publicly-traded company’s shares outstanding now amounts to $27.43 million, simultaneously with a float of $22.06 million. The organization now has a market capitalization sitting at $1.71 billion. At the time of writing, stock’s 50-day Moving Average stood at $77.30, while the 200-day Moving Average is $47.69.
GeneDx Holdings Corp (WGS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. GeneDx Holdings Corp’s current insider ownership accounts for 19.68%, in contrast to 69.01% institutional ownership. According to the most recent insider trade that took place on Jan 29 ’25, this organization’s CHIEF FINANCIAL OFFICER sold 275 shares at the rate of 78.48, making the entire transaction reach 21,582 in total value, affecting insider ownership by 2,950. Preceding that transaction, on Jan 29 ’25, Company’s Chief Executive Officer sold 1,657 for 78.48, making the whole transaction’s value amount to 130,046. This particular insider is now the holder of 3,937 in total.
GeneDx Holdings Corp (WGS) Earnings and Revenue Records
GeneDx Holdings Corp’s EPS increase for this current 12-month fiscal period is 94.88% and is forecasted to reach 0.55 in the upcoming year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Let’s observe the current performance indicators for GeneDx Holdings Corp (WGS). It’s Quick Ratio in the last reported quarter now stands at 2.27. The Stock has managed to achieve an average true range (ATR) of 7.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.39.
In the same vein, WGS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.17, a figure that is expected to reach 0.16 in the next quarter, and analysts are predicting that it will be 0.55 at the market close of one year from today.
Technical Analysis of GeneDx Holdings Corp (WGS)
If we take a close look at the recent performances of GeneDx Holdings Corp (NASDAQ: WGS), its last 5-days Average volume was 1.64 million that shows progress from its year to date volume of 1.05 million. During the previous 9 days, stock’s Stochastic %D was recorded 21.71% While, its Average True Range was 7.38.
Raw Stochastic average of GeneDx Holdings Corp (WGS) in the period of the previous 100 days is set at 41.74%, which indicates a major rise in contrast to 8.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 76.81% that was lower than 96.64% volatility it exhibited in the past 100-days period.
